<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">34962444</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>02</Month>
        <Day>02</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>02</Month>
        <Day>02</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">2222-1751</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>11</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Dec</Month>
            </PubDate>
          </JournalIssue>
          <Title>Emerging microbes &amp; infections</Title>
          <ISOAbbreviation>Emerg Microbes Infect</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Direct neuronal infection of SARS-CoV-2 reveals cellular and molecular pathology of chemosensory impairment of COVID-19 patients.</ArticleTitle>
        <Pagination>
          <StartPage>406</StartPage>
          <EndPage>411</EndPage>
          <MedlinePgn>406-411</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/22221751.2021.2024095</ELocationID>
        <Abstract>
          <AbstractText>Patients with recent pandemic coronavirus disease 19 (COVID-19) complain of neurological abnormalities in sensory functions such as smell and taste in the early stages of infection. Determining the cellular and molecular mechanism of sensory impairment is critical to understand the pathogenesis of clinical manifestations, as well as in setting therapeutic targets for sequelae and recurrence. The absence of studies utilizing proper models of human peripheral nerve hampers an understanding of COVID-19 pathogenesis. Here, we report that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) directly infects human peripheral sensory neurons, leading to molecular pathogenesis for chemosensory impairments. An in vitro system utilizing human embryonic stem cell (hESC)-derived peripheral neurons was used to model the cellular and molecular pathologies responsible for symptoms that most COVID-19 patients experience early in infection or may develop as sequelae. Peripheral neurons differentiated from hESCs expressed viral entry factor ACE2, and were directly infected with SARS-CoV-2 via ACE2. Human peripheral neurons infected with SARS-CoV-2 exhibited impaired molecular features of chemosensory function associated with abnormalities in sensory neurons of the olfactory or gustatory organs. Our results provide new insights into the pathogenesis of chemosensory dysfunction in patients with COVID-19.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Lyoo</LastName>
            <ForeName>Kwang-Soo</ForeName>
            <Initials>KS</Initials>
            <AffiliationInfo>
              <Affiliation>Korea Zoonosis Research Institute, Jeonbuk National University, Iksan, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kim</LastName>
            <ForeName>Hyeon Myeong</ForeName>
            <Initials>HM</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biomedical Science, Graduate School, Kyung Hee University, Seoul, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lee</LastName>
            <ForeName>Bina</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacology, Institute of Health Sciences, College of Medicine, Gyeongsang National University, Jinju, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Che</LastName>
            <ForeName>Young Hyun</ForeName>
            <Initials>YH</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biomedical Science, Graduate School, Kyung Hee University, Seoul, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kim</LastName>
            <ForeName>Seong-Jae</ForeName>
            <Initials>SJ</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Ophthalmology, Institute of Health Sciences, Gyeongsang National University School of Medicine and Gyeongsang National University Hospital, Jinju, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Song</LastName>
            <ForeName>Daesub</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacy, Korea University, Sejong, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hwang</LastName>
            <ForeName>Woochang</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>Biostatistical Consulting and Research Lab, Medical Research Collaborating Center, Hanyang University, Seoul, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lee</LastName>
            <ForeName>Sun</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pathology, School of Medicine, Kyung Hee University, Seoul, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Park</LastName>
            <ForeName>Jae-Hoon</ForeName>
            <Initials>JH</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pathology, School of Medicine, Kyung Hee University, Seoul, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Na</LastName>
            <ForeName>Woonsung</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Veterinary Virology, College of Veterinary Medicine, Chonnam National University, Gwangju, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yun</LastName>
            <ForeName>Seung Pil</ForeName>
            <Initials>SP</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacology, Institute of Health Sciences, College of Medicine, Gyeongsang National University, Jinju, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kim</LastName>
            <ForeName>Yong Jun</ForeName>
            <Initials>YJ</Initials>
            <Identifier Source="ORCID">0000-0002-5374-712X</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Biomedical Science, Graduate School, Kyung Hee University, Seoul, Korea.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Pathology, School of Medicine, Kyung Hee University, Seoul, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016422">Letter</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Emerg Microbes Infect</MedlineTA>
        <NlmUniqueID>101594885</NlmUniqueID>
        <ISSNLinking>2222-1751</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>EC 3.4.17.23</RegistryNumber>
          <NameOfSubstance UI="C000705307">ACE2 protein, human</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 3.4.17.23</RegistryNumber>
          <NameOfSubstance UI="D000085962">Angiotensin-Converting Enzyme 2</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000085962" MajorTopicYN="N">Angiotensin-Converting Enzyme 2</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000857" MajorTopicYN="N">Olfaction Disorders</DescriptorName>
          <QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011984" MajorTopicYN="N">Sensory Receptor Cells</DescriptorName>
          <QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013651" MajorTopicYN="N">Taste Disorders</DescriptorName>
          <QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">SARS-CoV-2</Keyword>
        <Keyword MajorTopicYN="N">chemosensory impairment</Keyword>
        <Keyword MajorTopicYN="N">hESC-derived peripheral neurons</Keyword>
        <Keyword MajorTopicYN="N">infection modelling</Keyword>
        <Keyword MajorTopicYN="N">viral infection</Keyword>
      </KeywordList>
      <CoiStatement>No potential conflict of interest was reported by the author(s).</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>29</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>3</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>28</Day>
          <Hour>12</Hour>
          <Minute>10</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34962444</ArticleId>
        <ArticleId IdType="pmc">PMC8803065</ArticleId>
        <ArticleId IdType="doi">10.1080/22221751.2021.2024095</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Mao L, Jin H, Wang M, et al. . 
Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020 Jun 1;77(6):683–690.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7149362</ArticleId>
            <ArticleId IdType="pubmed">32275288</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brann DH, Tsukahara T, Weinreb C, et al. . 
Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia. Sci Adv. 2020 Jul 31;6(31):eabc5801.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32937591</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Meinhardt J, Radke J, Dittmayer C, et al. . 
Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat Neurosci. 2021 Feb;24(2):168–175.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">33257876</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hoffmann M, Kleine-Weber H, Schroeder S, et al. . 
SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020 Apr 16;181(2):271–280.e8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7102627</ArticleId>
            <ArticleId IdType="pubmed">32142651</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kurapati S, Sadaoka T, Rajbhandari L, et al. . 
Role of the JNK pathway in varicella-zoster virus lytic infection and reactivation. J Virol. 2017 Sep 1;91(17):e00640-17.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5553188</ArticleId>
            <ArticleId IdType="pubmed">28637759</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Katoh H, Shibata S, Fukuda K, et al. . 
The dual origin of the peripheral olfactory system: placode and neural crest. Mol Brain. 2011 Sep 23;4:34.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3215936</ArticleId>
            <ArticleId IdType="pubmed">21943152</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Munoz-Fontela C, Dowling WE, Funnell SGP, et al. . 
Animal models for COVID-19. Nature. 2020 Oct;586(7830):509–515.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8136862</ArticleId>
            <ArticleId IdType="pubmed">32967005</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wan Q, Song D, Li H, et al. . 
Stress proteins: the biological functions in virus infection, present and challenges for target-based antiviral drug development. Signal Transduct Target Ther. 2020 Jul 13;5(1):125.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7356129</ArticleId>
            <ArticleId IdType="pubmed">32661235</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sa Ribero M, Jouvenet N, Dreux M, et al. . 
Interplay between SARS-CoV-2 and the type I interferon response. PLoS Pathog. 2020 Jul;16(7):e1008737.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7390284</ArticleId>
            <ArticleId IdType="pubmed">32726355</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wehbe Z, Hammoud S, Soudani N, et al. . 
Molecular insights into SARS COV-2 interaction with cardiovascular disease: role of RAAS and MAPK signaling. Front Pharmacol. 2020;11:836.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7283382</ArticleId>
            <ArticleId IdType="pubmed">32581799</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shiers S, Ray PR, Wangzhou A, et al. . 
ACE2 and SCARF expression in human dorsal root ganglion nociceptors: implications for SARS-CoV-2 virus neurological effects. Pain. 2020 Nov;161(11):2494–2501.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7572821</ArticleId>
            <ArticleId IdType="pubmed">32826754</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Verstrepen K, Baisier L, De Cauwer H.. 
Neurological manifestations of COVID-19, SARS and MERS. Acta Neurol Belg. 2020 Oct;120(5):1051–1060.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7303437</ArticleId>
            <ArticleId IdType="pubmed">32562214</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gordon DE, Jang GM, Bouhaddou M, et al.  A SARS-CoV-2-human protein-protein interaction map reveals drug targets and potential drug-repurposing. bioRxiv. 2020 Mar 22.</Citation>
        </Reference>
        <Reference>
          <Citation>Islam AMMK, Khan MAAK.. 
Lung transcriptome of a COVID-19 patient and systems biology predictions suggest impaired surfactant production which may be druggable by surfactant therapy. Sci Rep. 2020 Nov 10;10(1):19395.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7656460</ArticleId>
            <ArticleId IdType="pubmed">33173052</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Winkler ES, Bailey AL, Kafai NM, et al. . 
SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function. Nat Immunol. 2020 Nov;21(11):1327–1335.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7578095</ArticleId>
            <ArticleId IdType="pubmed">32839612</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cooper KW, Brann DH, Farruggia MC, et al. . 
COVID-19 and the chemical senses: supporting players take center stage. Neuron. 2020 Jul 22;107(2):219–233.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7328585</ArticleId>
            <ArticleId IdType="pubmed">32640192</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fiani B, Covarrubias C, Desai A, et al. . 
A contemporary review of neurological sequelae of COVID-19. Front Neurol. 2020;11:640.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7324652</ArticleId>
            <ArticleId IdType="pubmed">32655489</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oh Y, Zhang F, Wang Y, et al. . 
Zika virus directly infects peripheral neurons and induces cell death. Nat Neurosci. 2017 Sep;20(9):1209–1212.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5575960</ArticleId>
            <ArticleId IdType="pubmed">28758997</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Trbojevic-Akmacic I, Petrovic T, Lauc G.. 
SARS-CoV-2 S glycoprotein binding to multiple host receptors enables cell entry and infection. Glycoconj J. 2021 Oct;38(5):611–623.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8450557</ArticleId>
            <ArticleId IdType="pubmed">34542788</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">34962444</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>02</Month>
        <Day>02</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>02</Month>
        <Day>02</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">2222-1751</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>11</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Dec</Month>
            </PubDate>
          </JournalIssue>
          <Title>Emerging microbes &amp; infections</Title>
          <ISOAbbreviation>Emerg Microbes Infect</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Direct neuronal infection of SARS-CoV-2 reveals cellular and molecular pathology of chemosensory impairment of COVID-19 patients.</ArticleTitle>
        <Pagination>
          <StartPage>406</StartPage>
          <EndPage>411</EndPage>
          <MedlinePgn>406-411</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/22221751.2021.2024095</ELocationID>
        <Abstract>
          <AbstractText>Patients with recent pandemic coronavirus disease 19 (COVID-19) complain of neurological abnormalities in sensory functions such as smell and taste in the early stages of infection. Determining the cellular and molecular mechanism of sensory impairment is critical to understand the pathogenesis of clinical manifestations, as well as in setting therapeutic targets for sequelae and recurrence. The absence of studies utilizing proper models of human peripheral nerve hampers an understanding of COVID-19 pathogenesis. Here, we report that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) directly infects human peripheral sensory neurons, leading to molecular pathogenesis for chemosensory impairments. An in vitro system utilizing human embryonic stem cell (hESC)-derived peripheral neurons was used to model the cellular and molecular pathologies responsible for symptoms that most COVID-19 patients experience early in infection or may develop as sequelae. Peripheral neurons differentiated from hESCs expressed viral entry factor ACE2, and were directly infected with SARS-CoV-2 via ACE2. Human peripheral neurons infected with SARS-CoV-2 exhibited impaired molecular features of chemosensory function associated with abnormalities in sensory neurons of the olfactory or gustatory organs. Our results provide new insights into the pathogenesis of chemosensory dysfunction in patients with COVID-19.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Lyoo</LastName>
            <ForeName>Kwang-Soo</ForeName>
            <Initials>KS</Initials>
            <AffiliationInfo>
              <Affiliation>Korea Zoonosis Research Institute, Jeonbuk National University, Iksan, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kim</LastName>
            <ForeName>Hyeon Myeong</ForeName>
            <Initials>HM</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biomedical Science, Graduate School, Kyung Hee University, Seoul, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lee</LastName>
            <ForeName>Bina</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacology, Institute of Health Sciences, College of Medicine, Gyeongsang National University, Jinju, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Che</LastName>
            <ForeName>Young Hyun</ForeName>
            <Initials>YH</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biomedical Science, Graduate School, Kyung Hee University, Seoul, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kim</LastName>
            <ForeName>Seong-Jae</ForeName>
            <Initials>SJ</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Ophthalmology, Institute of Health Sciences, Gyeongsang National University School of Medicine and Gyeongsang National University Hospital, Jinju, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Song</LastName>
            <ForeName>Daesub</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacy, Korea University, Sejong, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hwang</LastName>
            <ForeName>Woochang</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>Biostatistical Consulting and Research Lab, Medical Research Collaborating Center, Hanyang University, Seoul, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lee</LastName>
            <ForeName>Sun</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pathology, School of Medicine, Kyung Hee University, Seoul, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Park</LastName>
            <ForeName>Jae-Hoon</ForeName>
            <Initials>JH</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pathology, School of Medicine, Kyung Hee University, Seoul, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Na</LastName>
            <ForeName>Woonsung</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Veterinary Virology, College of Veterinary Medicine, Chonnam National University, Gwangju, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yun</LastName>
            <ForeName>Seung Pil</ForeName>
            <Initials>SP</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacology, Institute of Health Sciences, College of Medicine, Gyeongsang National University, Jinju, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kim</LastName>
            <ForeName>Yong Jun</ForeName>
            <Initials>YJ</Initials>
            <Identifier Source="ORCID">0000-0002-5374-712X</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Biomedical Science, Graduate School, Kyung Hee University, Seoul, Korea.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Pathology, School of Medicine, Kyung Hee University, Seoul, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016422">Letter</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Emerg Microbes Infect</MedlineTA>
        <NlmUniqueID>101594885</NlmUniqueID>
        <ISSNLinking>2222-1751</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>EC 3.4.17.23</RegistryNumber>
          <NameOfSubstance UI="C000705307">ACE2 protein, human</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 3.4.17.23</RegistryNumber>
          <NameOfSubstance UI="D000085962">Angiotensin-Converting Enzyme 2</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000085962" MajorTopicYN="N">Angiotensin-Converting Enzyme 2</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000857" MajorTopicYN="N">Olfaction Disorders</DescriptorName>
          <QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011984" MajorTopicYN="N">Sensory Receptor Cells</DescriptorName>
          <QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013651" MajorTopicYN="N">Taste Disorders</DescriptorName>
          <QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">SARS-CoV-2</Keyword>
        <Keyword MajorTopicYN="N">chemosensory impairment</Keyword>
        <Keyword MajorTopicYN="N">hESC-derived peripheral neurons</Keyword>
        <Keyword MajorTopicYN="N">infection modelling</Keyword>
        <Keyword MajorTopicYN="N">viral infection</Keyword>
      </KeywordList>
      <CoiStatement>No potential conflict of interest was reported by the author(s).</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>29</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>3</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>28</Day>
          <Hour>12</Hour>
          <Minute>10</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34962444</ArticleId>
        <ArticleId IdType="pmc">PMC8803065</ArticleId>
        <ArticleId IdType="doi">10.1080/22221751.2021.2024095</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Mao L, Jin H, Wang M, et al. . 
Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020 Jun 1;77(6):683–690.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7149362</ArticleId>
            <ArticleId IdType="pubmed">32275288</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brann DH, Tsukahara T, Weinreb C, et al. . 
Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia. Sci Adv. 2020 Jul 31;6(31):eabc5801.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32937591</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Meinhardt J, Radke J, Dittmayer C, et al. . 
Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat Neurosci. 2021 Feb;24(2):168–175.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">33257876</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hoffmann M, Kleine-Weber H, Schroeder S, et al. . 
SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020 Apr 16;181(2):271–280.e8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7102627</ArticleId>
            <ArticleId IdType="pubmed">32142651</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kurapati S, Sadaoka T, Rajbhandari L, et al. . 
Role of the JNK pathway in varicella-zoster virus lytic infection and reactivation. J Virol. 2017 Sep 1;91(17):e00640-17.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5553188</ArticleId>
            <ArticleId IdType="pubmed">28637759</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Katoh H, Shibata S, Fukuda K, et al. . 
The dual origin of the peripheral olfactory system: placode and neural crest. Mol Brain. 2011 Sep 23;4:34.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3215936</ArticleId>
            <ArticleId IdType="pubmed">21943152</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Munoz-Fontela C, Dowling WE, Funnell SGP, et al. . 
Animal models for COVID-19. Nature. 2020 Oct;586(7830):509–515.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8136862</ArticleId>
            <ArticleId IdType="pubmed">32967005</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wan Q, Song D, Li H, et al. . 
Stress proteins: the biological functions in virus infection, present and challenges for target-based antiviral drug development. Signal Transduct Target Ther. 2020 Jul 13;5(1):125.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7356129</ArticleId>
            <ArticleId IdType="pubmed">32661235</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sa Ribero M, Jouvenet N, Dreux M, et al. . 
Interplay between SARS-CoV-2 and the type I interferon response. PLoS Pathog. 2020 Jul;16(7):e1008737.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7390284</ArticleId>
            <ArticleId IdType="pubmed">32726355</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wehbe Z, Hammoud S, Soudani N, et al. . 
Molecular insights into SARS COV-2 interaction with cardiovascular disease: role of RAAS and MAPK signaling. Front Pharmacol. 2020;11:836.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7283382</ArticleId>
            <ArticleId IdType="pubmed">32581799</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shiers S, Ray PR, Wangzhou A, et al. . 
ACE2 and SCARF expression in human dorsal root ganglion nociceptors: implications for SARS-CoV-2 virus neurological effects. Pain. 2020 Nov;161(11):2494–2501.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7572821</ArticleId>
            <ArticleId IdType="pubmed">32826754</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Verstrepen K, Baisier L, De Cauwer H.. 
Neurological manifestations of COVID-19, SARS and MERS. Acta Neurol Belg. 2020 Oct;120(5):1051–1060.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7303437</ArticleId>
            <ArticleId IdType="pubmed">32562214</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gordon DE, Jang GM, Bouhaddou M, et al.  A SARS-CoV-2-human protein-protein interaction map reveals drug targets and potential drug-repurposing. bioRxiv. 2020 Mar 22.</Citation>
        </Reference>
        <Reference>
          <Citation>Islam AMMK, Khan MAAK.. 
Lung transcriptome of a COVID-19 patient and systems biology predictions suggest impaired surfactant production which may be druggable by surfactant therapy. Sci Rep. 2020 Nov 10;10(1):19395.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7656460</ArticleId>
            <ArticleId IdType="pubmed">33173052</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Winkler ES, Bailey AL, Kafai NM, et al. . 
SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function. Nat Immunol. 2020 Nov;21(11):1327–1335.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7578095</ArticleId>
            <ArticleId IdType="pubmed">32839612</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cooper KW, Brann DH, Farruggia MC, et al. . 
COVID-19 and the chemical senses: supporting players take center stage. Neuron. 2020 Jul 22;107(2):219–233.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7328585</ArticleId>
            <ArticleId IdType="pubmed">32640192</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fiani B, Covarrubias C, Desai A, et al. . 
A contemporary review of neurological sequelae of COVID-19. Front Neurol. 2020;11:640.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7324652</ArticleId>
            <ArticleId IdType="pubmed">32655489</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oh Y, Zhang F, Wang Y, et al. . 
Zika virus directly infects peripheral neurons and induces cell death. Nat Neurosci. 2017 Sep;20(9):1209–1212.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5575960</ArticleId>
            <ArticleId IdType="pubmed">28758997</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Trbojevic-Akmacic I, Petrovic T, Lauc G.. 
SARS-CoV-2 S glycoprotein binding to multiple host receptors enables cell entry and infection. Glycoconj J. 2021 Oct;38(5):611–623.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8450557</ArticleId>
            <ArticleId IdType="pubmed">34542788</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
